Showing items 101–181
Chemical compounds, compositions and methods for kinase modulation
Grant US-8604032-B2
United States of America
Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof
Grant US-8569323-B2
United States of America
Anti-PD-L1 antibodies and uses therefor
Grant US-8552154-B2
United States of America
Methods of treating cancer with human monoclonal antibodies to CTLA-4
Grant US-8491895-B2
United States of America
Human CTLA-4 antibodies and their uses
Grant US-8318916-B2
United States of America
Methods of treatment using CTLA-4 antibodies
Grant US-8142778-B2
United States of America
Human monoclonal antibodies to CTLA-4
Grant US-8143379-B2
United States of America
Tumor cells with increased immunogenicity and uses therfor
Grant US-8026224-B2
United States of America
Human CTLA-4 antibodies and their uses
Grant US-8017114-B2
United States of America
Human monoclonal antibodies to CTLA-4
Grant US-7824679-B2
United States of America
Human monoclonal antibodies to CTLA-4
Grant US-7807797-B2
United States of America
ANTIBODIES SPECIFICALLY DIRECTED TO THE SOLUBLE FORM OF CTLA-4
Application WO-2010097597-A1
World Intellectual Property Organisation (WIPO)
Activation and expansion of T-cells using an engineered multivalent signaling platform as…
Grant US-7745140-B2
United States of America
Chimeric receptor genes and cells transformed therewith
Grant US-7741465-B1
United States of America
Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use…
Grant US-7722868-B2
United States of America
Activation and expansion of T-cells using an agent that provides a primary activation…
Grant US-7670781-B2
United States of America
Nucleic acid molecules encoding B7-1
Grant US-7619078-B2
United States of America
Human CTLA-4 antibodies and their uses
Grant US-7605238-B2
United States of America
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific…
Grant US-7592007-B2
United States of America
Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific…
Grant US-7510713-B2
United States of America
Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies
Grant US-7510712-B2
United States of America
Methods of producing 7C10 and 16C10 CD80-specific antibodies
Grant US-7501264-B2
United States of America
Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-speci…
Grant US-7491393-B2
United States of America
Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39…
Grant US-7476385-B2
United States of America
Nucleic acids encoding B7-2 fusion proteins
Grant US-7459544-B2
United States of America
Host cells expressing 7C10 and 16C10 CD80-specific antibodies
Grant US-7425447-B2
United States of America
7C10 and 16C10 CD80-specific antibodies
Grant US-7417128-B2
United States of America
Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies
Grant US-7414123-B2
United States of America
Nucleic acids encoding human monoclonal antibodies to CTLA-4
Grant US-7411057-B2
United States of America
Anti-CD80 antibodies
Application EP-1914301-A1
European Patent Office
Methods for treating HIV infected subjects
Grant US-7232566-B2
United States of America
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
Grant US-7229628-B1
United States of America
CD80 specific antibodies
Grant US-7192585-B2
United States of America
Treating intestinal inflammation with anti-CD80 antibodies that do not inhibit CD80…
Grant US-7175847-B1
United States of America
T cell costimulatory polypeptides containing alternative domains
Grant US-7153934-B2
United States of America
Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding…
Grant US-7153508-B2
United States of America
Methods for selectively stimulating proliferation of T cells
Grant US-7144575-B2
United States of America
Methods and host cells for producing human monoclonal antibodies to CTLA-4
Grant US-7132281-B2
United States of America
Methods for expressing and recovering human monoclonal antibodies to CTLA-4
Grant US-7109003-B2
United States of America
Depsipeptide and congeners thereof for use as immunosuppressants
Grant US-7041639-B2
United States of America
Methods of treating HIV infected subjects
Grant US-6905680-B2
United States of America
Methods for selectively stimulating proliferation of T cells
Grant US-6905681-B1
United States of America
T cell receptor ligands and methods of using same
Grant US-6900024-B2
United States of America
Methods for selectively stimulating proliferation of T cells
Grant US-6887466-B2
United States of America
Therapeutic uses of depsipeptides and congeners thereof
Grant US-6828302-B1
United States of America
Methods for inhibiting the interaction of B7-2 with its natural ligand
Grant US-6824779-B1
United States of America
Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
Grant US-6723705-B1
United States of America
Anergy associated genes
Application US-6709840-B1
United States of America
Human monoclonal antibodies to CTLA-4
Grant US-6682736-B1
United States of America
Methods for modulating T cell responses by manipulating intracellular signal transduction
Grant US-6632789-B1
United States of America
B7-specific antibodies
Grant US-6608180-B2
United States of America
Therapeutic compositions for inhibiting the interactions of B7-1 and B7-2 with their…
Grant US-6605279-B2
United States of America
Methods for stimulating T cell responses by manipulating a common cytokine receptor γ…
Grant US-6576236-B1
United States of America
Therapeutic uses of depsipeptides and congeners thereof
Grant US-6548479-B1
United States of America
Methods for selectively stimulating proliferation of T cells
Grant US-6534055-B1
United States of America
Methods and materials for modulation of the immunosuppresive activity and toxicity of…
Grant US-6491916-B1
United States of America
Methods for stimulating T cell responses to tumor cells expressing LFA-3 and a CD28 or…
Grant US-6451305-B1
United States of America
COMPOSITIONS AND USE THEREOF FOR DOWNMODULATING THE IMMUNE RESPONSE TO THERAPEUTIC…
N/A LT-4920-B
Lithuania
Methods of stimulating the immune system with anti-CD3 antibodies
Grant US-6406696-B1
United States of America
Depsipeptide and congeners thereof for use as immunosuppressants
Grant US-6403555-B1
United States of America
Methods for inducing a population of T cells to proliferate using agents which recognize…
Grant US-6352694-B1
United States of America
Pharmaceutical compositions thereof, and methods of using same
Grant US-6337316-B1
United States of America
Tumor cells with increased immunogenicity and uses therefor
Grant US-6319709-B1
United States of America
B7-1 and B7-2 polypeptides
Grant US-6218510-B1
United States of America
Nucleic acid based inhibition of CD40
Grant US-6194150-B1
United States of America
Tumor cells with increased immunogenicity and uses therefor
Grant US-6149905-A
United States of America
Methods of promoting immunopotentiation and preparing antibodies with anti-CD3 antibodies
Grant US-6143297-A
United States of America
Methods of stimulating or enhancing the immune system with anti-CD3 antibodies
Grant US-6113901-A
United States of America
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
Grant US-6051227-A
United States of America
T-cell receptor ligands and methods of using same
Grant US-5958712-A
United States of America
T cell receptor ligands and methods of using same
Grant US-5948409-A
United States of America
Treatment for insulin dependent diabetes
Grant US-5888507-A
United States of America
CD9 antigen peptides and antibodies thereto
Grant US-5883223-A
United States of America
B7-1 targeted ribozymes
Grant US-5877021-A
United States of America
Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
Grant US-5861310-A
United States of America
Tumor cells with increased immunogenicity and uses therefor
Grant US-5858776-A
United States of America
Methods for selectively stimulating proliferation of T cells
Grant US-5858358-A
United States of America
Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the…
Grant US-5846827-A
United States of America
T cell receptor ligands and methods of using same
Grant US-5837477-A
United States of America
Transgenic animal model for autoimmune diseases
Grant US-5718883-A
United States of America
Showing items 101–181